long COVID
-
healthACTIV-6 Trial: Metformin Reduces Clinician-Diagnosed Long COVID Risk
The ACTIV-6 randomized trial reveals metformin lowers clinician-diagnosed long COVID by 50% in immune outpatients, despite missing primary endpoints for patient-reported symptom prevention at six months.
-
healthOnline Singing Program Eases Long COVID Symptoms in UK Study
A large UK study finds ENO Breathe, an online singing program, improves quality of life and reduces breathlessness and anxiety in long COVID patients.
-
healthLong-Hantavirus: Survivors Face Months of Lingering Symptoms
New research shows hantavirus survivors suffer persistent symptoms months after infection, revealing a long-recovery phase similar to Long COVID.
-
healthLong COVID Prevalence Plateaus in U.S. Adults, Study Finds
New data shows long COVID rates stable from 2023-2024, with persistent functional limitations affecting daily activities for millions.
-
healthLong COVID's Economic Toll: Billions Lost Annually
A new study reveals the staggering annual economic cost of Long COVID across OECD countries, projected to reach over $135 billion, impacting GDP and healthcare systems.
-
healthLong COVID's Staggering Economic Toll: OECD Faces €116 Billion Annual Hit
New OECD report reveals the substantial, long-term economic burden of Long COVID on member countries, projecting billions in annual losses and highlighting the need for sustained attention.
-
healthLong COVID Taste Loss Tied to Molecular Changes, Not Structural Damage
New research finds persistent taste dysfunction in long COVID stems from reduced PLCβ2 and TAS1R3 gene expression-not nerve damage or lingering virus.
-
healthVitamin D May Reduce Risk of Long COVID, Study Finds
A Mass General Brigham study suggests high-dose vitamin D supplementation could lower the risk of developing long COVID symptoms.